MedTrace Logo

Gene Therapy to Improve Wound Healing in Patients With Diabetes

NCT00065663 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2007-11-20

No results posted yet for this study

Summary

Patients with diabetes may develop chronic wounds that respond poorly to treatment. Gene therapy with the platelet-derived growth factor-B gene has been shown to help with the healing of chronic wounds. This study will evaluate a new way to deliver the gene to the wound tissue.

Conditions

  • Wounds and Injuries
  • Diabetes
  • Diabetic Foot Ulcers
  • Foot Wounds

Interventions

GENETIC

GAM501

Sponsors & Collaborators

  • Tissue Repair Company

    lead INDUSTRY

Principal Investigators

  • Barbara Sosnowski, PhD · Tissue Repair Company

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Completion
2004-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00065663 on ClinicalTrials.gov